Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.67
+0.41001.04%
Post-market: 39.30-0.3700-0.93%17:40 EDT
Volume:75.33K
Turnover:2.97M
Market Cap:259.84M
PE:- -
High:39.69
Open:39.05
Low:39.05
Close:39.26
52wk High:41.49
52wk Low:22.18
Shares:6.55M
Float Shares:6.55M
Volume Ratio:0.54
T/O Rate:1.15%
Dividend:0.28
Dividend Rate:0.71%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Shares Down 5.6% Premarket After Co Announces Proposed Private Placement of $2 Bln of Convertible Senior Notes

THOMSON REUTERS
·
Aug 27

Moderna: Announces Proposed Private Placement of $2.0 Bln of Convertible Senior Notes

THOMSON REUTERS
·
Aug 27

Moderna: to Buy Hedge Overlay Intended to Offset Dilution up to a Cap Initially Equal to at Least a 150% Premium to the Stock Price at Pricing

THOMSON REUTERS
·
Aug 27

Becton Dickinson announces STANCE clinical trial enrollment milestone

TIPRANKS
·
Aug 27

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)

TIPRANKS
·
Aug 27

Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026

TIPRANKS
·
Aug 27

Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.

TIPRANKS
·
Aug 27

Revolution Medicines, Inc. : Oppenheimer Raises Target Price to $260 from $230

THOMSON REUTERS
·
Aug 27

24H | Okta Soars 21%; Salesforce Jumps 13%; CrowdStrike Rallies 10%; NVIDIA Climbs 4.6%

US Overnight
·
Aug 27

Moderna Inc. Stock Falls 5.8%, Underperforms Peers

Dow Jones
·
Aug 27

US Closing Bell | Wall St drifts lower as Dow dips 0.2%, Lumentum jumps 6%

US Closing Bell
·
Aug 27

Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat

Reuters
·
Aug 27

Cboe data shows mixed options sentiment in Moderna with shares down 7.64%

TIPRANKS
·
Aug 27

Roche receives FDA approval for companion diagnostic tests for Ziihera

TIPRANKS
·
Aug 27

Revolution Medicines Prices Metastatic Pancreatic Cancer Drug Rasonque at $39,800 a Month

MT Newswires Live
·
Aug 27

Revolution Medicines to Charge $39,800 a Month for Pancreatic Cancer Drug, Bloomberg Reports

MT Newswires Live
·
Aug 27

Revolution Medicines - Rasonque is NOW Commercially Available in the U.S. at a Wholesale Acquisition Cost of $39,800 for a 30-Day Supply - Conf Call

THOMSON REUTERS
·
Aug 27

Revolution Medicines Posts Investor Presentation on Rasonque FDA Approval

Reuters
·
Aug 27

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

TIPRANKS
·
Aug 27

Revolution Medicines announces FDA approval of Rasonque in adults

TIPRANKS
·
Aug 27